TITLE

The results of surgical treatment of metastatic liver tumor

AUTHOR(S)
Petrović, Tomislav; Majdevac, Ivan; Budišin, Nikola; Radovanović, Zoran; Nikolić, Ivan; Nikin, Zoran; Gavrančić, Brane; Mihailović, Jasna
PUB. DATE
July 2010
SOURCE
Archive of Oncology;2010, Vol. 18 Issue 1/2, p14
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The aim of our study was to analyze the survival of patients who were operated from liver metastases. This paper is a retrospective study of the case reports from the Clinic for Operative Oncology - Oncology Institute of Vojvodina. The study included all the patients treated operatively for secondary malignant liver tumors in the period from May 2003 to May 2007. Methods: The study included 33 patients (17 men and 16 women). The mean age of patients was 57.8 years (range, 27-75 years). In 23 patients, (69.7%) metastases were of colorectal origin, while in 10 patients (30.3%) metastases originated from some other organs. Results: Hepatectomies were performed in 54.54% and metastasectomies in 45.45% of patients.More severe postoperative complications (which required repeated surgery) were registered in 3.03% of patients. Intraoperative mortality was 3.03% and postoperative mortality was 12.12%. Liver re-resection was performed in 21.21% of patients. An overall one-year survival was 75.76%, and a tree-year survival was 43.75%. One-year survival in patients with colorectal metastases was 86.96% and three-year survival was 50%, while in patients with metastases originating from some other organs, one-year survival was 70% and three-year survival was only 25%. Intrahospital mortality in patients with colorectal metastases was 8.7% while in patients with non-colorectal metastases it was 30%. Conclusion: The aim of this paper was to show that only surgical removal of metastases can lead to life quality improvement and to prolongation of the overall survival and that modern neoadjuvant and biological therapies may increase resectability of the inoperable changes.
ACCESSION #
57627863

 

Related Articles

  • Causes of death within 1 year of resection for lung cancer. Early mortality after resection. Toker, Alper; Dilege, Sukru; Ziyade, Sedat; Eroglu, Osman; Tanju, Serhan; Yilmazbayhan, Dilek; Kilicarslan, Zeki; Kalayci, Goksel // European Journal of Cardio-Thoracic Surgery;Apr2004, Vol. 25 Issue 4, p515 

    Objectives: Some of the lung cancer patients who are treated surgically with curative intent ultimately die in the early postoperative period. The aim of this study is to analyze the causes of death within 1 year of resection for lung cancer in our patients. Methods: Six hundred and twenty...

  • LATERO-CERVICAL NECK DISSECTION IN MALIGNANT TUMOR PATHOLOGY. A STATISTICAL SURVIVAL OF ITS OWN. Făgeţan, I. M. // Acta Medica Transilvanica;jun2011, Vol. 16 Issue 2, p219 

    Understanding the biological progression of metastatic disease ,with origin at the level of head and neck towards the cervico-facial node stations, allowed the development of changes in classic radical neck dissection, in order to reduce morbidity and maintain therapeutic effectiveness

  • Removal of urothelial metastases shows promise. Newman, Laura // Urology Times;Jul2001, Vol. 29 Issue 7, p12 

    Reports that metastasectomy following chemotherapy may enhance long-term disease control in patients with urothelial cancers as of July 2001. Details of the study presented during the American Society of Clinical Oncology's year 2001 meeting held in San Francisco, California.

  • Port-site metastasis after minimally invasive cancer surgery. Shpitz, B.; Klein, E. // Surgical Endoscopy;Sep2003, Vol. 17 Issue 9, p1503 

    Presents a letter to the editor commenting on an article about port-site metastasis after minimally invasive cancer surgery.

  • Journal abstracts.  // Palliative Medicine;1999, Vol. 13 Issue 3, p265 

    Discusses the abstract of the article `The Management of Metastatic Bone Disease in the United Kingdom,' published in a 1999 issue of the `European Journal of Surgical Oncology.'

  • Recent Advances in the Management of Stage IV Colon Cancer. Kanthan, Rani; Senger, Jenna-Lynn; Ahmed, Shahid; Kanthan, Selliah // Journal of Cancer Therapy;Dec2012, Vol. 3 Issue 6, p1104 

    Colon cancer is the second commonest cause of cancer-related death in Canadian men and women, with approximately one-third of patients dying from this disease. One quarter of patients present with metastases initially, and up to half of all colon cancer patients will develop stage IV disease...

  • Surgery in asymptomatic patients with colorectal cancer and unresectable liver metastases: the authors' experience. Boselli, Carlo; Renzi, Claudio; Gemini, Alessandro; Castellani, Elisa; Trastulli, Stefano; Desiderio, Jacopo; Corsi, Alessia; Barberini, Francesco; Cirocchi, Roberto; Santoro, Alberto; Parisi, Amilcare; Redler, Adriano; Noya, Giuseppe // OncoTargets & Therapy;2013, Vol. 6, p267 

    Purpose: In asymptomatic patients with Stage IV colorectal cancer, the debate continues over the efficacy of primary resection compared to chemotherapy alone. The aim of this study was to define the optimal management for asymptomatic patients with colorectal cancer and unresectable liver...

  • Tanı anında uzak metastazı olan papiller tiroid kanserli hastalarda lenf nodu tutulumunun klinik önemi. Turanlı, Sevim; Karaman, Niyazi; Özçelik, Kazım Çağlar; Çetin, Abdullah // Journal of Dialog in Endocrinology / Endokrinolide Diyalog Dergi;Mar2012, Vol. 9 Issue 1, p12 

    Aim: To confirm the clinical significance of cervical lymph node metastasis in papillary thyroid cancer patients with distant metastasis at the time of diagnosis and to examine the location of prophylactic dissection. Materials and methods: Hospital records of 25 consecutive patients treated...

  • Surgery and adjuvant therapies in the treatment of stage IV melanoma: our experience in 84 patients. Tauceri, Francesca; Mura, Gianni; Roseano, Mauro; Framarini, Massimo; Ridolfi, Laura; Verdecchia, Giorgio // Langenbeck's Archives of Surgery;Nov2009, Vol. 394 Issue 6, p1079 

    Survival rates of patients with stage IV melanoma are poor: Median survival is 7–8 months and 5-year survival rates about 5%. There is no agreement on the role of surgery at this stage. Most patients with metastatic melanoma are not able to undergo resection and usually are sent to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics